FDA official logo
GSRS logo
PFDA official logo

VIBOSTOLIMAB

  • UNII: 5XO3JF0FEK
  • Preferred Substance Name: VIBOSTOLIMAB

  • 2231305-30-7
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT (T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)) (HUMAN-MUS MUSCULUS MONOCLONAL C011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C011 .KAPPA.-CHAIN, DIMER
  • MK7684
  • MK-7684
  • MK-7684A COMPONENT VIBOSTOLIMAB
  • T-CELL IMMUNOGLOBULIN AND IMMUNORECEPTOR TYROSINE-BASED INHIBITORY MOTIF INHIBITOR MK-7684
  • TIGIT INHIBITOR MK-7684
  • TIGIT-TARGETING AGENT MK-7684
  • VIBOSTOLIMAB [INN]
  • VIBOSTOLIMAB [USAN]
  • VIBOSTOLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.